Nov. 18, 2025
Envoy Medical Reaches Six-Month Milestone for 10 Patients in Acclaim Cochlear Implant Trial
WHITE BEAR LAKE, MINNESOTA — Envoy Medical® Inc. (NASDAQ: COCH) announced that the first 10 participants in the initial stage of its pivotal clinical trial for the investigational Acclaim® fully implanted cochlear implant have completed their six-month follow-up visits. According to the company, no serious adverse events have been reported to date. The six-month milestone marks continued progress in evaluating the












